PharmaShell’s layers are built atom-by-atom. [Illustration courtesy of Nanexa] Novo (NYSE: NVO) has tapped the Swedish drug-delivery developer Nanexa to develop long-acting injectable platforms for ...
The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation ...
The Eversense 365 CGM. [Image courtesy of Senseonics] Senseonics (NYSE:SENS) and Welldoc today announced a strategic partnership to develop a new custom mobile application for Eversense 365. Eversense ...
Left: the Abbott FreeStyle Libre 3 CGM. Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing ...
Abbott has been a standout in the CGM market with its FreeStyle Libre CGM portfolio. [Freestyle Libre 2 sensor photo from Adobe Stock] Millions of people worldwide are looking for ways to manage their ...
The new dual glucose-ketone sensor is built on the FreeStyle Libre 3 CGM form factor — meaning it’s the same size as two U.S. pennies stacked together. [Image courtesy of Abbott] About three years ago ...
The MiniMed 780G and Instinct sensor made by Abbott. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the ...
[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump. Pivot, a tubeless patch pump, ...
The Smart Basal offering with the G7 CGM. [Images courtesy of Dexcom] Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer. The ...
Abbott, Dexcom, Medtronic, Roche and Insulet represent the top five largest diabetes tech companies in the world. [Images from the companies] What has changed in the last year as diabetes technology ...
The twiist (left) and Eversense E3 (right) systems. [Images courtesy of Sequel Med Tech and Senseonics] Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results